We are live on ! Find out more
CTXR icon

Citius Pharmaceuticals
CTXR

9 hedge funds and large institutions have $700K invested in Citius Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.39% less ownership

Funds ownership: 0.49% → 0.09% (-0.39%)

18% less funds holding

Funds holding: 11 → 9 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

80% less capital invested

Capital invested by funds: $3.58M → $700K (-$2.88M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$14.2K
2
Jane Street
Jane Street
New York
+$6.37K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.47M
2
SM
Sabby Management
Florida
-$640K
3
BAAM
Baker Avenue Asset Management
California
-$70K
4
MIM
Miller Investment Management
Pennsylvania
-$15K
5
VF
Virtu Financial
New York
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$477K – – –
AWM
2
Argent Wealth Management
Massachusetts
$168K +$96.3K +6,578 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$25K +$14.2K +971 New
RJA
4
Raymond James & Associates
Florida
$12K – – –
Jane Street
5
Jane Street
New York
$11K +$6.37K +435 New
Bank of America
6
Bank of America
North Carolina
$2K -$2.31K -158 -71%
Wells Fargo
7
Wells Fargo
California
$2K – – –
CP
8
Corbenic Partners
Pennsylvania
$2K +$1.05K +72 New
LTFS
9
Ladenburg Thalmann Financial Services
Florida
$1K – – –
AC
10
Armistice Capital
New York
– -$2.47M -87,895 Closed
SM
11
Sabby Management
Florida
– -$640K -33,817 Closed
BAAM
12
Baker Avenue Asset Management
California
– -$70K -3,715 Closed
MIM
13
Miller Investment Management
Pennsylvania
– -$15K -800 Closed
VF
14
Virtu Financial
New York
– -$13K -661 Closed
HCM
15
Hilton Capital Management
New York
– -$1K -27 Closed

CTXR Hedge Fund Activity: Q4 2019 in Review

9 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals (CTXR) for Q4 2019, worth a combined $700K — down 80% from $3.58M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CTXR and 4 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $14.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.47M sold.

  • 9 institutional investors held Citius Pharmaceuticals (CTXR) as of Q4 2019, down from 11 in Q3 2019.
  • Funds reported $700K of Citius Pharmaceuticals stock for Q4 2019, down 80% quarter-over-quarter.
  • 4 funds opened new Citius Pharmaceuticals positions in Q4 2019 and 6 closed out, a net change of -2 holders.
  • The largest Citius Pharmaceuticals buyer in Q4 2019 was Susquehanna International Group, an estimated $14.2K added.
  • The largest Citius Pharmaceuticals seller in Q4 2019 was Armistice Capital, an estimated $2.47M sold.

Based on aggregated 13F filings for Q4 2019.